Skip to main content

Tarsus Pharmaceuticals, Inc 10-Q for FY2022 Q2

Tarsus Pharmaceuticals, Inc. (TARS)

10-Q 2022-08-11 For: 2022-06-30
View Original
Added on April 04, 2026

About this 10-Q

Tarsus Pharmaceuticals, Inc filed this 10-Q on August 11, 2022, covering the quarter ended June 30, 2022 (FY2022 Q2).

Headline figures

Quarter ended June 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$15.28M
down 30.6% from $22.02M a year earlier
Net loss
$5.74M
compared with net income of $6.35M a year earlier
Diluted EPS
-$0.24
compared with $0.29 a year earlier